https://www.selleckchem.com/pr....oducts/enfortumab-ve
e compared with the data of the LGT group. Data from low-, medium- and high-dose Morin groups showed no statistically significant differences ( 0.05). The findings suggest that Morin improved experimental autoimmune thyroiditis in rats through regulating NLRP3/Caspase-1 pathway. The findings suggest that Morin improved experimental autoimmune thyroiditis in rats through regulating NLRP3/Caspase-1 pathway. The purpose of this study was to investigate the protective effect of astragaloside Ⅳ (AS-Ⅳ) on neonatal rats' hy
Like
Comment
Share
